- Home
- FMS
as of 08-24-2026 11:00am EST
Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.
| Founded: | 1996 | Country: | Germany |
| Employees: | N/A | City: | N/A |
| Market Cap: | 13.6B | IPO Year: | 2005 |
| Target Price: | $30.00 | AVG Volume (30 days): | 787.5K |
| Analyst Decision: | Sell | Number of Analysts: | 2 |
| Dividend Yield: | Dividend Payout Frequency: | N/A | |
| EPS: | N/A | EPS Growth: | N/A |
| 52 Week Low/High: | $20.02 - $27.64 | Next Earning Date: | 05-05-2026 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | -0.22% | Revenue Growth (next year): | 3.83% |
| P/E Ratio: | 15.62 | Index: | N/A |
| Free Cash Flow: | N/A | FCF Growth: | +4.67% |
Compare FMS vs Leading Stocks
See how FMS stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "FMS Fresenius Medical Care AG - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.